Clinical Trials
11 trialsNCT07277387 2026-04-23
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Instituto de Investigación Biomédica de Salamanca
Not yet recruiting
NCT03683329 2026-02-19
DéPOH
Institut Paoli-Calmettes
Phase 3 Completed
NCT04203524 2025-03-17
Pro-Can
King Hussein Cancer Center
Phase NA Terminated
NCT06005558 2024-07-05
Low Dose Versus High Dose Methylene Blue in Septic Patients
National Cancer Institute, Egypt
Phase 2/3 Completed
NCT03837171 2024-06-25
TRANSPORT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT05443854 2022-07-05
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT01718613 2018-05-18
VANCS II
Instituto do Cancer do Estado de São Paulo
Phase 3 Completed
NCT01172132 2016-04-18
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"
Assistance Publique - Hôpitaux de Paris
Completed
NCT01600989 2014-04-25
MitoSepsis
Insel Gruppe AG, University Hospital Bern
Completed
NCT01304680 2012-11-29
Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock
Grupo de Apoio ao Adolescente e a Crianca com Cancer
Unknown
NCT00930085 2011-09-14
PROTEOHSEPS
Institut Paoli-Calmettes
Phase NA Completed